Bxp agrees to sell a 45% interest in kendall square life sciences properties

Boston--(business wire)--bxp (nyse: bxp), the largest publicly traded developer, owner, and manager of premier workplaces in the united states, today announced that it has entered into agreements to sell a 45% interest in two life sciences development properties located in kendall square in cambridge, massachusetts, to norges bank investment management at a gross valuation of approximately $1.66 billion or $2,050 per square foot. the properties – 290 binney street and 300 binney street – total.
BXP Ratings Summary
BXP Quant Ranking